Cargando…
Dexamethasone may affect the occurrence of parenteral nutrition-associated cholestasis in preterm neonates
INTRODUCTION: Glucocorticoids are currently used for the co-therapeutic management of autoimmune hepatitis and some cholestatic diseases. Thus far, we do not know the efficacy of glucocorticoids in the treatment of parenteral nutrition-associated cholestasis. We aimed to analyze whether the administ...
Autores principales: | Jiang, Saizhi, Hu, Qingqing, Zhang, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772609/ https://www.ncbi.nlm.nih.gov/pubmed/36568435 http://dx.doi.org/10.3389/fped.2022.1023798 |
Ejemplares similares
-
Ursodeoxycholic Acid and SMOFlipid for Treating Parenteral Nutrition Associated Cholestasis in Infants
por: Al-Alaiyan, Saleh, et al.
Publicado: (2022) -
Light protection of parenteral nutrition, cholestasis, and other prematurity-related morbidities in premature infants
por: Clauss, Christie, et al.
Publicado: (2022) -
Parenteral nutrition associated cholestasis
por: Costa, Simonetta, et al.
Publicado: (2015) -
Total parenteral nutrition-associated cholestasis and risk factors in preterm infants
por: Alkharfy, Turki M., et al.
Publicado: (2014) -
Mdr3 gene mutation in preterm infants with parenteral nutrition‐associated cholestasis
por: Yang, Xiufang, et al.
Publicado: (2022)